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Background: We studied assembly of HBV 
capsids using a genetically-fused dimer. 
Results: Assembly intermediates composed of 
two, three and five copies of a fused dimer have 
been isolated. 
Conclusion: Capsid assembly could progress 
using dimeric, trimeric and pentameric 
intermediates. 
Significance:  The low abundance and transient 
nature of assembly intermediates make analysis 
challenging, however, the stability of the 
intermediates described here has overcome this. 
 
SUMMARY 
Macromolecular complexes are responsible 
for many key biological processes. However, 
in most cases details of the 
assembly/disassembly of such complexes are 
unknown at the molecular level, as the low 
abundance and transient nature of assembly 
intermediates make analysis challenging. The 
assembly of virus capsids is an example of 
such a process. The hepatitis B virus capsid 
(core) can be composed of either 90 or 120 
dimers of coat protein. Previous studies have 
proposed a trimer of dimers as an important 
intermediate species in assembly, acting to 
nucleate further assembly by dimer addition. 
Using novel genetically-fused coat protein 
dimers, we have been able to trap higher-
order assembly intermediates and to 
demonstrate for the first time that both 
dimeric and trimeric complexes are on 
pathway to virus-like particle (capsid) 
formation. 
 
Viruses, such as hepatitis B virus 
(HBV), present as ideal candidates for the study 
of a range of biological processes, including 
macromolecular assembly. The core protein 
(Cp, also known as HBcAg) of HBV assembles, 
together with the pregenomic RNA (pgRNA) 
and the viral polymerase, into icosohedral 
nucleocapsids. Within these particles the 
pgRNA is reverse transcribed into DNA, the 
genomic form present in infectious virions (1). 
However, Cp alone is able to assemble into 
icosohedral virus-like particles (VLPs) in vitro, 
indistinguishable from the nucleocapsids 
formed in infected cells. These icosahedral 
capsids can be composed of either 90 or 120 
dimers of Cp (T numbers 3 and 4, respectively). 
Cp is therefore in three possible quasi-
equivalent environments in T=3 capsids and 
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four in T=4 (Fig. 1A). The protein has two 
domains. Residues 1-149 form the assembly 
domain, necessary and sufficient for capsid 
assembly whereas the C-terminal nucleic acid 
binding domain is required in vivo (2). Evidence 
suggests that the latter domain is largely 
disordered (3), whereas the assembly domain is 
composed of five Į-helices, lacking the 
FDQRQLFDO ȕ-barrel structure prevalent in many 
capsid proteins. Its tertiary structure can be 
characterised as each monomer forming half of 
an upturned T (Fig. 1). Helices three and four 
comprise the dimer interface, or the T stalk. 
Helix five, together with the subsequent loop 
region, forms inter-dimer contacts that mediate 
capsid assembly at the two- and five-fold 
icosahedral axes. At the distal end of helix five, 
tyrosine-132 extends from the loop. This 
residue is essential for capsid assembly and 
contributes a significant proportion of buried 
hydrophobic surface at the inter-dimer 
interfaces (4,5).  
The quasi-equivalent environments are 
largely super-imposable with structural 
deviations being mostly confined to helix five, 
the proceeding loop and unstructured region (5).  
Assembly is not fully understood and although a 
wealth of kinetic and thermodynamic 
information exists (6-13), the pathway to capsid 
formation has yet to be elucidated in detail. Cp 
forms stable non-covalent dimers in solution 
and assembly can be initiated in vitro by 
increasing ionic strength (14). This is thought to 
act by inducing a conformational change in the 
dimer from assembly inactive to assembly 
active forms. This hypothesis is supported by 
the crystal structure of the Y132A assembly-
defective mutant revealing subtle changes in 
structure compared to that in the context of the 
capsid (15).  In silico assembly modelling 
suggests assembly progresses from a nucleation 
complex of a trimer of dimers (6). In addition, 
mass spectrometry analysis has demonstrated 
the presence of a number of species of up to 12 
dimers, including a dimer of dimers and trimer 
of dimers (16). More recently, a combination of 
mass spectrometry and cryo-EM has revealed 
the presence of kinetically-trapped incomplete 
capsids, which may represent intermediates later 
in assembly (13). While these observations are 
plausible (given that kinetic trapping is likely to 
trap assembly intermediates), assembly of the 
trapped species has not been followed on to the 
formation of intact capsids. 
Previously, modified proteins have been 
employed to make investigation of 
macromolecular complexes more tractable. 
Pentamers of the HIV-1 capsid protein were 
isolated using artificially introduced disulphide 
linkages and, alternatively, template-driven 
assembly using fusion proteins (17). In addition, 
a C-terminal truncation of the E2 core of 
pyruvate dehydrogenase from Bacillus 
stearothermophilus was used to isolate and 
characterise a trimeric intermediate in the E2 
cage assembly pathway (18). Indeed, the vast 
majority of previous studies of hepatitis B core 
assembly have used a truncated Cp 
incorporating the N-terminal assembly domain 
only. Removal of the C-terminal domain allows 
capsid disassembly/reassembly studies to be 
performed in vitro. We have incorporated a 
further modification into the assembly domain 
in order to investigate the capsid assembly 
process and to facilitate the use of these VLPs 
as generic scaffolds for antigen presentation 
(19). We have engineered a genetically-fused 
dimer (termed fused Cp) in which two copies of 
the Cp assembly domain (referred to as WT Cp) 
have been tethered with a C-N terminal peptide 
linker. This is shown as a cartoon in Figure 1B. 
Both WT and fused Cp capsids have been 
produced in E. coli.  
Here, we have shown that disassembly 
reactions of capsids composed of dimers of WT 
Cp resulted in the release of non-covalent Cp 
dimers, as expected. In contrast, disassembly of 
the fused Cp capsids yielded several products, 
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corresponding to a monomer, dimer and trimer 
of the fused Cp as well as possible higher-order 
species.  Assembly reactions using these species 
successfully yielded fully assembled capsids. 
Furthermore, assembly reactions in which 
assembly of these species was allowed to 
progress in the presence of WT Cp dimers 
resulted in capsids that were a mixture of fused 
and WT Cp, consistent with the oligomeric 
complexes being incorporated into the newly 
formed capsids. These data suggest that the 
complexes are assembly-competent and 
therefore represent intermediates on pathway to 
fully assembled capsids.  
 
EXPERIMENTAL PROCEEDURES 
Plasmid Constructs - All constructs 
were cloned using the pET28b vector system. 
The fused Cp included a 5 x GGS sequence, 
designed to link the C-terminus of one assembly 
domain to the N-terminus of the other (shown as 
a cartoon for illustrative purposes in Fig. 1 B). 
The construct (also termed tandem core CoHo) 
also included changes to the c/e1 loops to 
incorporate novel restriction sites. A full 
description of this construct and the generation 
of other fused Cp variants has been published 
elsewhere (19), together with a description of 
expression and characterisation in both 
prokaryotic and eukaryotic systems and 
presentation of foreign epitopes.  
Protein Expression and Purification - 
E. coli BL21 DE3 cells were grown to OD600 
0.6 - 0.8 at 37 oC. Protein was expressed 
overnight at 16 oC following induction with 1 
mM IPTG. Cells were lysed by French press 
and resulting lysates clarified by centrifugation 
at 50000 x g for 1hour. Protein was precipitated 
from clarified lysates by the addition of solid 
ammonium sulphate to 40 %. The harvested 
precipitate was resuspended in 20 mM HEPES, 
pH 7.5 250 mM NaCl, 5 mM DTT and clarified 
at 10000 x g for 20 minutes followed by 20000 
x g for 10 minutes. Protein was subjected to 
sedimentation through linear 20-60 % sucrose 
density gradients in a Beckman AH629 rotor for 
3 hours at 4 oC followed by fractionation into 1 
ml fractions. Fractions containing Cp, as 
demonstrated by SDS-PAGE, were dialysed 
against 100 mM sodium bicarbonate, pH 9.6 
and DTT (2 and 5 mM for monomeric and fused 
dimer samples, respectively). Dialysis resulted 
in approximately 2.5 fold dilution of the protein. 
Solid urea was added to the dilute protein at 4 
oC for 3 hours to a final concentration of 3 or 4 
M (for samples of WT or fused Cp, 
respectively) and subsequently concentrated to 
DSSUR[LPDWHO\  $8 DW Ȝ    Qm. The 
concentrated protein was briefly sonicated (2 x 
5 seconds at 10 microns) then filtered through 
 ȝ0 PHPEUDQH 7KH UHVXOWLQJ SURWHLQ ZDV
separated by size exclusion chromatography 
using a 26/60 Superdex-200 column 
equilibrated with 100 mM sodium bicarbonate, 
pH 9.7 and 5 mM DTT (50 mM sodium 
bicarbonate, pH 9.6 and 2 mM DTT for 
monomeric Cp). Protein elution was monitored 
DW Ȝ    nm and peaks were analysed by 
native and SDS PAGE and by Western blotting 
and the fractions pooled accordingly. 
Transmission electron microscopy - 
Negative stain transmission electron microscopy 
(TEM) was performed as described in (20) 
using 4 % uranyl acetate. Samples were 
examined using a CM10 transmission electron 
microscope (Phillips, Guildford, UK). 
Molecular weight determination using 
size exclusion chromatography - Protein pooled 
from the original chromatographic separation 
was loaded onto a 26/60 Superdex-200 column 
and eluted at 1.0 ml min-1. The column had been 
calibrated using commercial molecular weight 
protein standards (BioRad). These proteins were 
used to construct a standard curve, from which 
the oligomers masses were derived.    
 Non-covalent mass spectrometry - 
Spectra were acquired using a Synapt HDMS 
orthogonal acceleration quadrupole-time-of-
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flight mass spectrometer (Micromass UK Ltd, 
Waters Corp., Wilmslow, UK). Oligomer 
samples isolated from size-exclusion 
chromatography were button-dialysed against 
100 mM ammonium acetate, pH 6.8, whereas 
the fused Cp samples were analysed in the same 
solution at pH 9.5. For the disassembly reaction 
analysed without prior size-exclusion 
separation, fused Cp capsids were dialysed into 
4 M urea, 50 mM ammonium acetate pH 9.5, 5 
mM DTT and incubated at 4° C for ~16 hours. 
The sample was then dialysed into 50 mM 
ammonium acetate pH 9.5, 5 mM DTT. The 
samples were electrosprayed from 
gold/platinum-plated borosilicate capillaries 
fabricated in-house using a P-97 micropipette 
puller (Sutter Instrument Company, Novato, 
CA) and a sputter coater (Polaron SC7620; 
Quorum Technologies Ltd, Kent, UK). The 
electrospray capillary voltage was set at 1.7 kV 
and the sample cone voltage at 40-60 V. To 
improve the resolution of the oligomer analyte 
signals, the voltage of the Transfer region of the 
mass spectrometer was increased to 50 V. The 
instrument had a source pressure of 3 mbar and 
a Trap gas (argon) flow rate of 2 ml min-1. Data 
were processed using the MassLynx (v 4.1) 
suite of software programs supplied with the 
instrument. 
Assembly reactions - Protein isolated 
from size exclusion chromatography was 
concentrated to a minimum of 0.2 mg ml-1 and 
subsequently dialysed into HEPES pH 7.5. 
Assembly was initiated by the addition of 
sodium chloride to a final concentration of 750 
mM. Reactions were incubated on ice for 
minimum of two hours, to ensure complete 
assembly. Capsids were visualised by TEM. 
Chased assembly reactions - Samples of 
fused Cp oligomers were separated by size 
exclusion chromatography and mixed at a 1:1 
ratio with samples of similarly purified WT Cp. 
Assembly of protein capsids was initiated with 
the addition of sodium chloride to 750 mM. 
Resulting assemblies were applied to a 10/30 
Superdex 75 size exclusion column and the Vo 
peak (representing assembled capsid) collected 
and fractions pooled. Capsids were 
immunoprecipitated from solution using 
antibody MAB16988 and protein G Sepharose 
beads. This antibody reacts with the wild-type 
c/e1 loops within the context of the capsid but 
has no reactivity against disassembled protein or 
the fused Cp. Protein was analysed by Western 
blot using Ab 10E11 (Abcam, Cambridge), 
reactive with all Cp protein samples. 
 
RESULTS 
Capsids composed of fused Cp 
disassemble into oligomeric complexes - 
Capsids composed of two different Cp variants 
(WT and fused Cp) were used in this study. 
Both Cps lacked the C-terminal domain, as 
described previously, for ease of 
disassembly/reassembly (21). The fused Cp 
consists of two WT Cp monomers linked 
between the C and N-termini with a 5 × GGS 
linker sequence. Capsids composed of WT or 
fused Cp were purified and subjected to 
disassembly. 3 M urea was sufficient to 
disassemble capsids composed of WT Cp  (8). 
However, it was necessary to increase urea 
concentration to at least 4 M to facilitate 
disassembly of capsids composed of fused Cp.   
Separation, using size exclusion 
chromatography (SEC), of WT samples resulted 
in two protein peaks, shown in the 
chromatogram, Fig. 2A. Both peaks contained 
Cp (predicted MW = 17.3 KDa) as shown by 
SDS-PAGE (Fig. 2B). However, protein from 
the first peak was unable to enter the matrix of a 
native-PAGE gel (Fig. 2) and was shown, by 
TEM, to contain particulate matter likely to be 
residual capsid not broken down by the 
disassembly process (Fig. 2Di). In contrast, 
material from the second peak was resolved as a 
single species by native PAGE (Fig. 2C). This 
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sample contained no discernible higher-order 
structures by TEM (Fig. 2Dii).  
In contrast, when the fused Cp capsids 
were subjected to the same process, at least four 
peaks resulted, as shown in Fig. 3A. The first 
(void volume) peak contained material 
corresponding to residual capsid but the ratio of 
disassembled material to residual capsid was 
reduced, indicating greater stability of capsids 
composed of fused Cp. Western blot analysis of 
SDS-PAGE of the peaks confirmed the presence 
of fused Cp in each, as expected (Fig. 3B). 
However, the peaks from the chromatogram 
migrated differently from each other when 
separated by native PAGE (Fig. 3C). Together, 
these results indicated that these species were 
oligomeric complexes of the fused Cp. We 
found no evidence of oligomeric complexes 
during disassembly of WT Cp capsids (Fig. 2). 
However, it remains quite possible that higher-
order complexes were present (in equilibrium 
with the oligomers) at levels too low to detect. 
Although the presence of the fused Cp 
oligomers could still be detected after a week, 
samples had a propensity to spontaneously 
aggregate and precipitate from solution, 
indicative that they may be in equilibrium with 
lower and higher-order oligomers. This was 
countered by maintaining the proteins in high 
pH buffer (a known assembly inhibitor (22)). 
Although dialysis into neutral pH buffer often 
resulted in precipitation; this was cleared by 
centrifugation prior to analysis of the protein.     
Identification and characterisation of 
the fused Cp oligomeric complexes - To 
determine the solution molecular weights of the 
fused oligomers, samples of each were 
separately re-analysed using SEC on a 
calibrated Superdex-200 column, Fig. 4A. The 
elution profile was used to calculate the 
molecular masses of the oligomers based on the 
calibration curve of molecular weight standards. 
Extrapolated mass values were 34.6, 93.8 and 
181.7 kDa. These equate to ~1, 2-3 and 5 copies 
of the fused Cp (~36 kDa). However, this 
technique can often lead to an over-estimation 
of mass. Therefore, these samples were also 
subjected to electrospray ionisation-mass 
spectrometry (ESI-MS) under non-denaturing 
conditions (Fig. 4B) (23,24). Using this 
technique, the fused Cp was clearly detected 
with a mass of 36,224 Da (Fig. 4Bi) and the 
oligomers observed were identified as dimers 
and trimers of the fused Cp, with measured 
masses of 72,471 and 109,070 Da, respectively 
(Figs. 4Bii and iii). The high value obtained for 
the latter by SEC could be due to the presence 
of higher mass oligomers in the sample (Fig. 
4A) but could also reflect differences in 
dynamics, as discussed previously (25). In order 
to characterise these low-abundance oligomers 
further, samples of fused Cp capsids were 
subjected to disassembly and ESI-MS analysis 
without SEC purification. In this mixed sample, 
oligomers with masses corresponding to two-
five copies (inclusive) of the fused Cp were 
detected, with measured mass values of 72,400, 
108,777, 145,384 and 182,935 Da, respectively 
(Fig. 4Biv). It is possible that the identification 
of the tetramer and pentamer of fused Cp in this 
sample was due to the absence of SEC 
purification, which can lead to the loss of 
material, resulting in lower concentration. 
Furthermore, the different abundances of the 
oligomers relative to those seen in the SEC 
chromatogram may be due to the different 
buffer conditions used. Nevertheless, the data 
agree qualitatively with SEC and provide a 
more accurate measurement of mass and 
therefore a more confident assignment of the 
oligomeric states of the fused Cp formed in the 
disassembly process. 
 
Oligomers of fused Cp are on pathway 
for assembly into capsids -  Assembly reactions, 
akin to those previously documented (7), were 
carried out to determine if the samples 
corresponding to dimers or trimers of fused Cp 
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were competent for assembly into capsids. 
Samples of each protein at ~0.2 mg ml-1 were 
treated with NaCl to a final concentration of 750 
mM and assembly allowed to proceed for 
minimum of two hours on ice. Protein samples 
were then analysed by TEM which showed the 
presence of capsids in each of the samples (Fig. 
5). This suggested that the three oligomers were 
competent for capsid assembly and, 
furthermore, that the oligomers were on 
pathway and were therefore assembly 
intermediates.  However, it is possible that 
contamination of samples with very small 
amounts of free fused dimer Cp could be 
responsible for the results observed.  
To confirm that the oligomers were 
indeed assembly-competent, we chased the 
assembly of each with WT Cp dimers. Samples 
of oligomers and WT Cp dimers were first 
purified using SEC, as described above. Capsid 
peaks were discarded and samples representing 
fused Cp, and dimers or trimers of fused Cp 
were mixed with WT Cp at 1:1 ratio (equimolar 
on the basis of mass). Reassembly was triggered 
with NaCl, as above and it was clearly 
demonstrated by SEC of the assembly reactions 
that all oligomers were assembly-competent 
(Fig. 6A). In order to characterise the 
composition of these capsids, we exploited the 
use of a monoclonal antibody to the c/e1 loop 
(MAB16988, Millipore). This antibody is able 
to recognise capsids composed of WT Cp (but 
not free Cp dimers) and is unable to recognise 
fused Cp under any conditions due to 
modifications of the c/e1 loops. We also 
employed an antibody (10E11) that was able to 
recognise all of these Cp proteins.  Reassembled 
capsids (Fig. 6A) were isolated and 
immunoprecipitated with the c/e1 antibody, 
thereby removing any unassembled protein and 
ensuring that only capsids that incorporated the 
WT Cp would be isolated. To probe for the 
presence of the fused Cp in these reassembled 
capsids, samples were subjected to SDS PAGE 
and immunoblot with the 10E11 antibody (Fig. 
6B). A control sample of WT Cp dimers was 
included and was detected (after reassembly and 
immunoprecipitation) as a single Cp band, as 
expected. In contrast, the presence of both WT 
and fused Cp was detected in the capsids 
reassembled from the peak fraction samples, 
indicating clearly that both the dimeric and 
trimeric oligomers of fused Cp identified above 
were assembly-competent and constitute viable 
intermediate species on the pathway to capsid 
formation. 
 
 
DISCUSSION 
 The assembly of macromolecular 
complexes is still poorly understood as pathway 
intermediates are often in very low abundance 
and transient in nature. Here, we have identified 
intermediates in the pathway of the assembly of 
the HBV capsid by exploiting novel assembly–
competent fused dimers of the capsid protein 
together a range of techniques including  non-
denaturing mass spectrometry. In previous 
studies using mass spectrometry to analyse WT 
Cp samples, the absolute masses of the capsids 
were determined to 0.1 % tolerance and several 
oligomers were observed (16,26). However, it 
was unclear whether these were on pathway to 
capsid assembly. Here, we have isolated and 
characterised similar oligomers. We have 
demonstrated previously that the fused Cp 
platform provides reduced flexibility (25)  and 
may help stabilisation of the intermediates, thus 
facilitating their detection and characterisation. 
Consistent with this, Selzer and colleagues (12) 
also recently reported the importance of 
structural flexibility and that constraining the 
intradimer interface (by formation of disulphide 
bonds) could affect kinetics and 
thermodynamics of assembly. Interestingly, in 
addition to slower assembly, their data also 
demonstrated a decrease in stability of capsids 
formed from the more rigid WT Cp dimers. The 
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unusual stability of the fused dimer oligomers 
here could be consistent with slower assembly 
kinetics, allowing their isolation and 
interrogation to a level not possible with other 
Cp variants. However, capsids composed of 
fused Cp appeared more stable relative to WT 
(at least in terms of urea denaturation). 
We have reassembled capsids produced 
from samples of fused Cp oligomers (dimers or 
trimers) together with WT protein. These 
capsids were shown to contain a mixture of both 
WT Cp and fused Cp, and this result provides 
strong evidence that the oligomers represent 
complexes on pathway to capsid assembly.  We 
have also shown the presence of species 
consistent with both tetramers and pentamers of 
Cp. Although these species may be assembly-
competent, it has not been possible to undertake 
definitive experiments because of their low 
abundance.  
Previous studies have suggested a 
trimer of dimers as the nucleus of HBV capsid 
assembly (6,16). It is also interesting to note 
that trimeric species have been identified as 
important assembly intermediates in other 
viruses (27). Indeed, from this work, it appears 
that this species is on pathway.  However, 
assembly may also continue via tetrameric and 
pentameric intermediates. The structure of the 
trimer of dimers here remains unknown. It is 
possible that it is a closed ring of subunits (Fig. 
7). However, it is tempting to speculate that it is 
an open structure, more competent to allow 
addition of further subunits i.e. corresponding to 
part of a five-fold particle axis. The presence of 
putative tetrameric and pentameric 
intermediates (identified here by mass 
spectrometry) would strongly support this. 
Using a related strategy, we previously 
demonstrated the presence of on-pathway 
intermediates in the assembly of bacteriophage 
MS2 capsids (28,29). As here, it remained a 
possibility that capsid assembly occurs due to 
the disassembly of higher-order oligomers into 
dimers, which are then assembly-competent, 
rather than by the direct involvement of the 
oligomers. It should be noted that this study and 
the work presented here were carried out in 
vitro and in the absence of HBV pgRNA and the 
viral polymerase. It is therefore possible that 
different assembly pathway/s may occur in vivo, 
however, detailed studies of this nature are yet 
to be completed for any virus. 
Our studies are continuing with the use 
of the HBV fused Cp system to present foreign 
antigens (via the modified c/e1 loops) as a novel 
vaccine platform, which we have termed tandem 
core.  
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FIGURE LEGENDS 
FIGURE 1. HBV structure (PDB: 1QBT).  A. 
The T=4 capsid structure, space fill (left) and 
ribbon diagram (right). The capsid is composed 
of 4 quasi-equivalent subunits (shown in red, 
yellow, blue and green) arranged as 120 dimers. 
It has an inner radius of 130 Å, is 20 Å thick 
and is punctuated by spikes that project 25 Å 
from the surface, giving a total radius of 175 Å. 
B. Cartoon representation of the fused Cp, based 
on structure in A. The MIR is indicated and the 
two Cp monomers are shown in green and 
yellow, with the linker in red.  
FIGURE 2. Disassembly of capsids composed 
of WT Cp. Protein at ~ 2 mg/ml was 
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disassembled with 3 M urea at pH 9.6. A. 
Chromatogram of protein separation on a 
Superdex 200 column (capsid and Cp peaks are 
indicated as Peaks 1 and 2, respectively). B. 
Reducing SDS PAGE of fractions. Both peaks 
contained protein of the same molecular weight, 
corresponding to the expected size of WT Cp 
(17.3 kDa) by comparison to the standards 
shown (LHS). C. Native PAGE of gel filtration 
fractions. Protein from the capsid peak did not 
enter the gel matrix, however, the Cp peak is 
well resolved to a single species. D. TEM 
(negative stain) of the two gel filtration peaks. i) 
capsid peak ii) Cp peak. Higher-order structures 
are visible in i) however, ii) is devoid of these. 
Bar = 100 nm.  
FIGURE 3. Disassembly of capsids composed 
of fused Cp. Capsids composed of fused dimers 
were disassembled with 4 M urea. A. Size-
exclusion chromatogram of fused Cp capsid 
disassembly reactions, resulting in a large peak 
consistent with non-dissociated capsid (Peak 1) 
and several other species labelled 2 to 4. Arrow 
indicates additional low abundance species, 
which were not isolated. B. Immunoblot of 
reducing SDS PAGE of samples 2-4. All of the 
peaks contained protein of the same molecular 
weight, which was Cp antibody (10E11) 
reactive. Positions of standards are shown for 
reference. C. Immunoblot of native PAGE of 
fractions. Proteins exhibited different migration 
patterns. The positive control (+) consists of Cp 
from disassembly of WT capsids. 
FIGURE 4. Biophysical analysis of the 
oligomeric species. A. Characterisation of the 
oligomers by size exclusion chromatography. 
Fractions of peaks 2-4 from the disassembly 
reaction were pooled and subjected to further 
SEC. Calibrated molecular weights were 
determined as 34.6 (i), 93.8 (ii), and 181.7 (iii) 
kDa. Labels i-iii correspond to those in part B. 
B. Non-covalent ESI-MS of the oligomers. 
Derived masses are consistent with a monomer 
(i), dimer (ii) and trimer (iii) of the fused Cp. 
(iv). Non-covalent ESI-MS of a mixed sample 
of oligomers, showing species corresponding to 
up to five copies of fused Cp.  
FIGURE 5. TEM of oligomer assembly 
reactions. Assembly was initiated by mixing 
samples of each complex with sodium chloride 
to a final concentration of 750 mM.  Symbols i, 
ii and iii relate to samples corresponding to 
fused Cp, and dimers or trimers of fused Cp, 
respectively. Micrographs (negative stain) of 
assembly reactions are shown, in the order 
corresponding to sample elution from size 
exclusion chromatography (see Fig. 3). The 
oligomers appear to be competent for assembly 
into capsids. Size bars = 100 nm. 
FIGURE 6. Chasing the assembly of protein 
oligomers with WT Cp. A. Samples of fused Cp 
oligomers and WT Cp dimers were purified as 
above. Capsid peaks were discarded and 
samples representing fused Cp dimers and 
trimers mixed with WT Cp at 1:1 ratio. 
Assembly was initiated with the addition of 
sodium chloride to 750 mM. The resulting 
reactions were separated by gel filtration 
chromatography using a S75 column. B. The 
void volume (capsid) peak was analysed. 
Capsids were immunoprecipitated from this 
using Mab 16988 (c/e1 loop specific and 
therefore unable to recognise fused Cp). 
Samples were analysed by immunoblot (using 
the 10E11 antibody to recognise all Cp variants) 
showing these to be chimeric particles 
composed of both WT Cp and fused Cp. The 
positive control (+) is purified WT Cp from 
disassembly of WT capsids. (-) corresponds to a 
sample with no Cp. Arrows indicate expected 
MW of WT Cp and fused Cp. * indicates 
antibody chains.  
FIGURE 7. Schematic of proposed assembly 
pathway, via either trimeric or pentameric 
intermediates. 
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